Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6121359 | Journal of Clinical Virology | 2013 | 6 Pages |
Abstract
Substitutions conferring resistance to NS5A RCIs pre-existed in treatment-naive patients infected with HCV GT3. The effectiveness of these NS5A RCIs to exert efficacy in the clinic may depend on which inhibitor is used in combination with other antivirals.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Dennis Hernandez, Nannan Zhou, Joseph Ueland, Aaron Monikowski, Fiona McPhee,